Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Current Assets (2016 - 2026)

Gyre Therapeutics has reported Current Assets over the past 16 years, most recently at $102.4 million for Q4 2025.

  • Quarterly Current Assets rose 58.01% to $102.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $102.4 million through Dec 2025, up 58.01% year-over-year, with the annual reading at $102.4 million for FY2025, 58.01% up from the prior year.
  • Current Assets was $102.4 million for Q4 2025 at Gyre Therapeutics, up from $98.6 million in the prior quarter.
  • Over five years, Current Assets peaked at $116.5 million in Q1 2021 and troughed at $5.1 million in Q3 2023.
  • The 5-year median for Current Assets is $60.0 million (2023), against an average of $60.9 million.
  • Year-over-year, Current Assets plummeted 90.63% in 2023 and then soared 967.99% in 2024.
  • A 5-year view of Current Assets shows it stood at $51.5 million in 2021, then fell by 3.54% to $49.7 million in 2022, then increased by 15.24% to $57.2 million in 2023, then increased by 13.22% to $64.8 million in 2024, then surged by 58.01% to $102.4 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Current Assets are $102.4 million (Q4 2025), $98.6 million (Q3 2025), and $91.3 million (Q2 2025).